» Articles » PMID: 22160698

Mature Clustered, Regularly Interspaced, Short Palindromic Repeats RNA (crRNA) Length is Measured by a Ruler Mechanism Anchored at the Precursor Processing Site

Overview
Specialty Science
Date 2011 Dec 14
PMID 22160698
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Precise RNA processing is fundamental to all small RNA-mediated interference pathways. In prokaryotes, clustered, regularly interspaced, short palindromic repeats (CRISPR) loci encode small CRISPR RNAs (crRNAs) that protect against invasive genetic elements by antisense targeting. CRISPR loci are transcribed as a long precursor that is cleaved within repeat sequences by CRISPR-associated (Cas) proteins. In many organisms, this primary processing generates crRNA intermediates that are subject to additional nucleolytic trimming to render mature crRNAs of specific lengths. The molecular mechanisms underlying this maturation event remain poorly understood. Here, we defined the genetic requirements for crRNA primary processing and maturation in Staphylococcus epidermidis. We show that changes in the position of the primary processing site result in extended or diminished maturation to generate mature crRNAs of constant length. These results indicate that crRNA maturation occurs by a ruler mechanism anchored at the primary processing site. We also show that maturation is mediated by specific cas genes distinct from those genes involved in primary processing, showing that this event is directed by CRISPR/Cas loci.

Citing Articles

AcrIIIA1 is a protein-RNA anti-CRISPR complex that targets core Cas and accessory nucleases.

Chou-Zheng L, Howell O, Boyle T, Hossain M, Walker F, Sheriff E Nucleic Acids Res. 2024; 52(22):13490-13514.

PMID: 39551936 PMC: 11662646. DOI: 10.1093/nar/gkae1006.


RNA processing by the CRISPR-associated NYN ribonuclease.

Chi H, White M Biochem J. 2024; 481(12):793-804.

PMID: 38785320 PMC: 11346440. DOI: 10.1042/BCJ20240151.


Type III CRISPR-Cas: beyond the Cas10 effector complex.

Stella G, Marraffini L Trends Biochem Sci. 2023; 49(1):28-37.

PMID: 37949766 PMC: 10844953. DOI: 10.1016/j.tibs.2023.10.006.


The biology and type I/III hybrid nature of type I-D CRISPR-Cas systems.

McBride T, Cameron S, Fineran P, Fagerlund R Biochem J. 2023; 480(7):471-488.

PMID: 37052300 PMC: 10212523. DOI: 10.1042/BCJ20220073.


Critical roles for 'housekeeping' nucleases in type III CRISPR-Cas immunity.

Chou-Zheng L, Hatoum-Aslan A Elife. 2022; 11.

PMID: 36479971 PMC: 9762709. DOI: 10.7554/eLife.81897.


References
1.
Terns M, Terns R . CRISPR-based adaptive immune systems. Curr Opin Microbiol. 2011; 14(3):321-7. PMC: 3119747. DOI: 10.1016/j.mib.2011.03.005. View

2.
Deveau H, Garneau J, Moineau S . CRISPR/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol. 2010; 64:475-93. DOI: 10.1146/annurev.micro.112408.134123. View

3.
Kreiswirth B, Lofdahl S, Betley M, OReilly M, Schlievert P, Bergdoll M . The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 1983; 305(5936):709-12. DOI: 10.1038/305709a0. View

4.
Wang R, Preamplume G, Terns M, Terns R, Li H . Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition and cleavage. Structure. 2011; 19(2):257-64. PMC: 3154685. DOI: 10.1016/j.str.2010.11.014. View

5.
Haurwitz R, Jinek M, Wiedenheft B, Zhou K, Doudna J . Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science. 2010; 329(5997):1355-8. PMC: 3133607. DOI: 10.1126/science.1192272. View